Latest dengue Stories
JAKARTA, Indonesia, June 14, 2011 /PRNewswire/ -- The Association of Southeast Asian Nations (ASEAN) launched the first ASEAN Dengue Day today in Indonesia, with related events occurring throughout the ASEAN member states.
Study shows Internet search queries can help monitor epidemics in developing countries; produces new Internet tool that could speed public health responses to tropical diseases BOSTON, May 31, 2011 /PRNewswire-USNewswire/ -- Researchers at Children's Hospital Boston and Google.org have found web-based search data to be a viable source of information for early detection and monitoring of outbreaks of dengue, an emerging mosquito-borne virus found in tropical areas of the world.
Major progress has been made in reducing the burden of infectious diseases in Brazil as part of a "remarkable" success story for health in the South American country.
SILVER SPRING, Md., April 8, 2011 /PRNewswire-USNewswire/ -- The U.S.
At least one dengue vaccine could be licensed within the next 4 years, as manufacturers are speeding up the development process for multiple dengue vaccine candidates in collaboration with health authorities and developing countries to expedite the necessary testing, clinical trial design, and licensure, a team of leading scientists said.
LYON, France, February 21, 2011 /PRNewswire-FirstCall/ -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that it is partnering with the International Vaccine Institute (IVI) to support the recently launched Dengue Vaccine Initiative (DVI).
Dengue illness, the most common mosquito-borne viral disease in the world, has expanded from its Southeast Asian origins and is resurgent in countries such as Argentina, Chile and the continental United States.
DEERFIELD, Illinios, February 4, 2011 /PRNewswire/ -- The first assessment of the total cost of dengue illness in the Americas reveals the economic burden to be approximately $2.1 billion per year, exceeding that from other viral illnesses including human papillomavirus (HPV) and rotavirus.
LYON, France, November 4, 2010 /PRNewswire-FirstCall/ -- - First Phase 3 Study Underway in Australia Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that its dengue vaccine is in final stage of clinical development.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced three new contracts to fund research on vaccines to protect against emerging infectious diseases and biological threats that could be used in a terror attack.
Dengue fever and dengue hemorrhagic fever (DHF), caused by the dengue virus, is among the spectrum of acute febrile tropical disease and is transmitted by mosquitoes. Occurring mainly in the tropics it can be life threatening and is caused by four closely related virus stereotypes of the genus Flavivirus. It was identified and named in 1779. It has a nickname of "breakbone fever" due to it causing sever generalized bodyache. It tends to be more prevalent in the urban districts of its range...
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.